Types of Cancer

Most malignant tumors show no obvious symptoms in the early stage, like hidden undercurrents. Early detection, early diagnosis, and early treatment are key strategies for defeating cancer. If you have suspicious symptoms or a family history of cancer, please seek medical care promptly and receive professional screening.

Prostate Cancer

Esophageal Cancer

Cervical Cancer

Nasopharyngeal Cancer

Laryngeal Cancer

Pancreatic Cancer

Multiple Myeloma

Malignant Melanoma

Endometrial Cancer

Gallbladder Cancer

Cholangiocarcinoma

Soft Tissue Sarcoma

Testicular Cancer

MDT Team

Bringing together senior experts in China's precision minimally invasive cancer treatment field to provide you with world-leading minimally invasive cancer treatment services.

Liao Zhengyin

PhD, West China Hospital, Sichuan UniversityPostdoctoral Fellow, Chinese PLA General Hospitals in Beijing, ChinaSenior Visiting Scholar at Johns Hopkins Hospital, USAProfessor and Grade 1 Expert in the Oncology Center at West China Hospital, Sichuan University

Extremely adept at minimally invasive interventional therapies for tumors and treatment of cancer pain, proficient in radioactive seed implantation, ablation, and vascular intervention, with a focus on liver cancer, lung cancer, pancreatic cancer, and bone metastases, and particularly skilled in radioactive seed implantation for refractory cancer pain.

Xiao Yueyong

Doctor of Medicine, Professor, and Doctoral Supervisor Chief Physician at Department of Radiological Diagnosis in the No. 1 Medical Center at Chinese PLA General Hospital

Doctor Xiao has an expertise in the individualised minimally-invasive ablation of solid tumours including liver cancer, lung cancer, and pancreatic cancer under the guidance of CT/MRI. Doctor Xiao is proficient in radiofrequency, microwave, cryoablation, and nanoknife ablation technologies, and operates more than thousands of operations annually. Especially, Dr. Xiao has abundant experiences in the precise treatment of the tumours in special anatomical sites such as hepatic hilar region, retroperitoneum, and mediastinal lymph nodes. Further, Dr. Xiao is rather good at combining chemical ablation and seed implantation therapies.

Zhang Jinshan

Chief PhysicianProfessorDoctoral Supervisor

He is very involved in treating tumors and blood vessel diseases, focusing on less invasive procedures for issues like liver cancer, cirrhotic portal hypertension, Budd–Chiari syndrome, narrowing and blockage of peripheral blood vessels, both benign and malignant tumors, and benign prostatic hyperplasia. He was among the first in China to perform advanced techniques such as TIPSS and B-ORTO, filling multiple domestic gaps in the field. He also pioneered temporary hepatic vein occlusion combined with hepatic arterial embolization for the treatment of liver cancer, led the development of standardized treatment protocols for liver cancer, and has made significant contributions to the advancement of interventional medicine in China.

Hu Xiaokun

Chief PhysicianProfessorDoctoral SupervisorPostdoctoral mentorDeputy Director of the Interventional Medicine Center of The Affiliated Hospital of Qingdao UniversityDirector of the Qingdao Tumor Interventional Minimally Invasive Technology Innovation Center.Visiting Scholar at Harvard Medical School, USA

Specializes in the treatment of solid tumors, including lung cancer, liver cancer, glioma, and pancreatic cancer, with a particular focus on radioactive iodine-125 seed implantation combined with multimodal ablation techniques such as microwave ablation, radiofrequency ablation, cryoablation, and irreversible electroporation (NanoKnife). Also possesses extensive experience in the management of non-neoplastic diseases, particularly vertebroplasty and minimally invasive treatments for intervertebral disc disorders.

Treatment Technologies

Providing targeted, world-class precision treatment solutions for patients worldwide.

Transarterial Chemoembolization (TACE)

It is primarily used for the palliative treatment of intermediate to advanced-stage primary liver cancer, liver metastases, and hypervascular tumors in areas such as the head, neck, and lungs. It can also be used as postoperative adjuvant chemotherapy to help reduce the risk of local recurrence.

NanoKnife Ablation Technology

It is primarily indicated for solid tumors located in anatomically complex regions adjacent to major blood vessels, bile ducts, pancreatic ducts, the intestines, or nerves—such as locally advanced pancreatic cancer, hilar hepatic tumors, renal hilar tumors, and prostate cancer. This technique offers a safe and effective option for curative or cytoreductive treatment in patients with unresectable lesions or tumors unsuitable for conventional thermal ablation.

Iodine-125 Seed Implantation Technology

It is primarily indicated for solid tumors that are unresectable, recurrent, or metastatic after radiotherapy and chemotherapy, including primary liver cancer, non-small cell lung cancer, prostate cancer, and pancreatic cancer, as well as recurrent or metastatic tumors of the head and neck and pelvic regions.

Argon-Helium Knife Ablation Therapy

It is widely used in the treatment of liver cancer, lung cancer, renal cancer, as well as bone and soft tissue tumors. The technique is particularly suitable for lesions adjacent to the thoracic or abdominal wall, adrenal glands, and multiple metastatic tumors, making it an important component of the minimally invasive ablation system for solid tumors.